Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

被引:227
作者
Thomas, DD
Espey, MG
Ridnour, LA
Hofseth, LJ
Mancardi, D
Harris, CC
Wink, DA
机构
[1] NCI, Tumor Biol Sect, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC USA
[3] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
关键词
cancer; hypoxia; macrophage; inducible NO synthase;
D O I
10.1073/pnas.0400453101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NO produced in tumors can either positively or negatively regulate growth. To examine this dichotomy, effects of NO concentration and duration on the posttranslational regulation of several key proteins were examined in human breast MCF7 cells under aerobic conditions. We found that different concentration thresholds of NO appear to elicit a discrete set of signal transduction pathways. At low steady-state concentrations of NO (<50 nM), extracellular signal-regulated kinase (ERK) phosphorylation was induced via a guanylate cyclase-dependent mechanism. Hypoxic inducible factor 1alpha (HIF-1alpha) accumulation was associated with an intermediate amount of NO (>100 nM), whereas p53 serine 15 phosphorylation occurred at considerably higher levels (>300 nM). ERK phosphorylation was transient during NO exposure. HIF-1alpha stabilization paralleled the presence of NO, whereas p53 serine 15 phosphorylation was detected during, and persisted after, NO exposure. The dose-dependent effects of synthetic NO donors were mimicked by activated macrophages cocultured with MCF7 cells at varying ratios. ERK and HIF-1alpha activation was similar in breast cancer cell lines either mutant (MB231) or null (MB157) in p53. The stabilization of HIF-1alpha by NO was not observed with increased MCF7 cell density, demonstrating the interrelationship between NO and O-2 consumption. The findings show that concentration and duration of NO exposure are critical determinants in the regulation of tumor-related proteins.
引用
收藏
页码:8894 / 8899
页数:6
相关论文
共 60 条
[1]   A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].
AHMED, SA ;
GOGAL, RM ;
WALSH, JE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224
[2]   P53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells [J].
Ambs, S ;
Merriam, WG ;
Ogunfusika, MO ;
Bennett, WP ;
Ishibe, N ;
Hussain, SP ;
Tzeng, EE ;
Geller, DA ;
Billiar, TR ;
Harris, CC .
NATURE MEDICINE, 1998, 4 (12) :1371-1376
[3]   Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice [J].
Ambs, S ;
Ogunfusika, MO ;
Merriam, WG ;
Bennett, WP ;
Billiar, TR ;
Harris, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8823-8828
[4]  
Ambs S, 1998, CANCER RES, V58, P334
[5]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[6]   Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas [J].
Benitz, BG ;
Barnes, MN ;
Haines, GK ;
Lurain, JR ;
Hanson, DG ;
Radosevich, JA .
TUMOR BIOLOGY, 1997, 18 (05) :290-300
[7]  
Bentz BG, 1998, HEAD NECK-J SCI SPEC, V20, P304, DOI 10.1002/(SICI)1097-0347(199807)20:4<304::AID-HED4>3.0.CO
[8]  
2-2
[9]   Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck [J].
Bentz, BG ;
Haines, GK ;
Lingen, MW ;
Pelzer, HJ ;
Hanson, DG ;
Radosevich, JA .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1999, 108 (08) :781-787
[10]   Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators [J].
Bozcuk, H ;
Uslu, G ;
Pestereli, E ;
Samur, M ;
Ozdogan, M ;
Karaveli, S ;
Sargin, F ;
Savas, B .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (03) :239-248